OpiCalc Logo

OpiCalc

989 Clinical Tools

Logo
OpiCalc
ACE-III (Cognitive Examination)AIMS (Tardive Dyskinesia)ASRM (Altman Mania Scale)ASRS-v1.1 (Adult ADHD Screen)ASSIST (WHO Substance Screen)AUDIT (Alcohol Use Disorders)AUDIT-C (Alcohol Screen)BARS (Akathisia)BDI-II (Beck Depression)BPRS (Brief Psychiatric Rating)BSDS (Bipolar Spectrum Screen)C-SSRS (Suicide Severity)CAGE QuestionnaireCAPS-5 (PTSD Clinical Interview)CDR (Dementia Staging)CDSS (Schizophrenia Depression)CIWA-Ar (Alcohol Withdrawal)COWS (Opioid Withdrawal)Clozapine Safety (REMS)DAST-10 (Drug Abuse Screen)DES-II (Dissociation Scale)EDE-Q (Eating Disorder Severity)EPDS (Postnatal Depression)Epworth Sleepiness ScaleFAST (Alzheimer's Staging)Fagerstrom (Nicotine Dependence)GAD-2 (Anxiety Screen)GAD-7 (Anxiety Severity)GAF (Global Functioning)HAM-D 17 (Hamilton Depression)HCL-32 (Hypomania Checklist)IES-R (Trauma Impact)ISI (Insomnia Severity)LSAS (Social Anxiety)MADRS (Depression Rating)MARSIPAN (Medical Risk in AN)MDQ (Bipolar Screen)MSI-BPD (Borderline PD Screen)Manchester Self-Harm RuleMetabolic Syndrome (Psych)MoCA (Cognitive Assessment)OCI-R (OCD Screen)PANSS (Schizophrenia Severity)PCL-5 (PTSD Checklist DSM-5)PHQ Panic ModulePHQ-2 (Depression Screen)PHQ-9 (Depression Severity)PSP (Personal/Social Performance)PSQI (Pittsburgh Sleep Quality)QTc Prolongation (Psychiatry)SAD PERSONS ScaleSAFE-T ProtocolSBQ-R (Suicidal Behaviors)SCOFF (Eating Disorder Screen)SPIN (Social Phobia)Simpson-Angus Scale (EPS)Y-BOCS (OCD Severity)YMRS (Mania Severity)
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

ProtocolsAboutPrivacyTerms

International Restless Legs Scale (IRLS)

IRLS: International Restless Legs Scale. Rate the following items based on your experience over the past week.

Sleep & Symptom Assessment (0/10)

1. In the past week, how would you rate the RLS discomfort in your legs or arms?

2. In the past week, how would you rate the need to move around because of your RLS symptoms?

3. In the past week, how much relief of your RLS arm or leg discomfort did you get from moving around?

4. In the past week, how severe was your sleep disturbance due to your RLS symptoms?

5. In the past week, how severe was your tiredness or sleepiness during the day due to your RLS symptoms?

6. In the past week, how severe was your RLS as a whole?

7. In the past week, how often did you get RLS symptoms?

8. In the past week, when you had RLS symptoms, how severe were they on average?

9. In the past week, how severe is the impact of your RLS symptoms on your ability to carry out your daily affairs?

10. In the past week, how severe was your mood disturbance due to your RLS symptoms?

Guidelines & Evidence

Clinical Details

Section 1

When to Use

When to Use

Monitoring symptom severity in patients already diagnosed with Restless Legs Syndrome (RLS)
Evaluating the effectiveness of pharmacotherapy (e.g., dopamine agonists, gabapentinoids)
Standardized assessment for RLS research and clinical trials
Symptom-tracking for patients reporting worsening sleep quality related to leg sensations
Section 2

Formula & Logic

Scoring Logic

The IRLS consists of 10 items assessing symptom frequency, intensity, and impact on sleep and daily function. Each item is rated from 0 to 4. Total scores range from 0 to 40.

Severity Interpretation

0 pointsNone
1–10 pointsMild
11–20 pointsModerate
21–30 pointsSevere
31–40 pointsVery Severe
Section 3

Evidence Appraisal

Validation

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome.

Walters AS et al. • Sleep Med.. 2003;4(2):121-32. Primary validation showing excellent test-retest reliability (0.87) and sensitivity to change.

The International Restless Legs Syndrome Study Group rating scale: touchstone for clinical trials.

Abetz L et al. • Sleep Med.. 2006;Demonstrated the scale's robustness across diverse cultural and clinical populations.

Last Comprehensive Review: 2026

Related Psychiatry Tools

CIWA-Ar
Clinical Institute Withdrawal Assessment for Benzodiazepines
COWS
Opioid Risk Tool
ASSIST
Fagerstrom
ASRS-v1.1
Conners' Adult ADHD Rating Scales
Cannabis Use Disorder Identification Test — Revised
SCOFF
Have feedback about this calculator?Let us know.